Novartis Chief Commits To Sandoz And Its German Headquarters

 
• By Aidan Fry

Novartis has no plans to sell Sandoz, nor to move the generics division’s headquarters from its current location in Holzkirchen, Germany. Legacy German brand Hexal also remains part of the company’s plans.

Holzkirchen Station
Sandoz will remain part of Novartis, headquartered in the German town of Holzkirchen, the Swiss group's CEO Vas Narasimhan has affirmed • Source: Shutterstock

More from Business

More from Generics Bulletin